- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
8
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
8 companies
AstraZeneca
Market Cap: UK£178.4b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£117.40
7D
-9.3%
1Y
4.6%
Gilead Sciences
Market Cap: US$162.8b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$135.27
7D
0.7%
1Y
20.3%
Chugai Pharmaceutical
Market Cap: JP¥11.0t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,680.00
7D
-4.6%
1Y
-9.2%
Orion Oyj
Market Cap: €11.2b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€80.40
7D
-0.4%
1Y
12.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥48.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥108.62
7D
-6.6%
1Y
8.9%
Xiamen Amoytop Biotech
Market Cap: CN¥23.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥57.56
7D
-0.05%
1Y
-34.9%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.95
7D
-1.2%
1Y
11.1%
PharmaResearch
Market Cap: ₩4.0t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩384,500.00
7D
2.4%
1Y
-31.8%